Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
View ORCID ProfileJesse Huang
doi: https://doi.org/10.1101/2020.10.02.20205609
Jesse Huang
1Kii Research Institute, Vancouver, Washington, USA
2Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Study data is available for request as of October 2, 2020.
Posted October 05, 2020.
Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
Jesse Huang
medRxiv 2020.10.02.20205609; doi: https://doi.org/10.1101/2020.10.02.20205609
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12959)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4770)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3026)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2361)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1229)
- Primary Care Research (515)
- Public and Global Health (7132)
- Radiology and Imaging (1586)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)